181 related articles for article (PubMed ID: 37956408)
1. Functional assay for assessment of pathogenicity of BAP1 variants.
Repo PE; Backlund MP; Kivelä TT; Turunen JA
Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
[TBL] [Abstract][Full Text] [Related]
2. Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT
Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963
[TBL] [Abstract][Full Text] [Related]
3. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
[TBL] [Abstract][Full Text] [Related]
4. BAP1 germline variants in Finnish patients with malignant mesothelioma.
Repo P; Staskiewicz A; Sutinen E; Rönty M; Tero T Kivelä ; Myllärniemi M; Turunen JA
Lung Cancer; 2022 Mar; 165():102-107. PubMed ID: 35114507
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
[TBL] [Abstract][Full Text] [Related]
6. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome.
Lalloo F; Kulkarni A; Chau C; Nielsen M; Sheaff M; Steele J; van Doorn R; Wadt K; Hamill M; Torr B; Tischkowitz M; ; Hanson H
Eur J Hum Genet; 2023 Nov; 31(11):1261-1269. PubMed ID: 37607989
[TBL] [Abstract][Full Text] [Related]
7. Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer.
Tesch ME; Pater JA; Vandekerkhove G; Wang G; Binnington K; So AI; Wyatt AW; Eigl BJ
NPJ Genom Med; 2020; 5():12. PubMed ID: 32218990
[TBL] [Abstract][Full Text] [Related]
8. Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.
Chau C; van Doorn R; van Poppelen NM; van der Stoep N; Mensenkamp AR; Sijmons RH; van Paassen BW; van den Ouweland AMW; Naus NC; van der Hout AH; Potjer TP; Bleeker FE; Wevers MR; van Hest LP; Jongmans MCJ; Marinkovic M; Bleeker JC; Jager MJ; Luyten GPM; Nielsen M
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31382694
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
[TBL] [Abstract][Full Text] [Related]
10. Diagnostics of
Sculco M; La Vecchia M; Aspesi A; Clavenna MG; Salvo M; Borgonovi G; Pittaro A; Witel G; Napoli F; Listì A; Grosso F; Libener R; Maconi A; Rena O; Boldorini R; Giachino D; Bironzo P; Maffè A; Alì G; Elefanti L; Menin C; Righi L; Tampieri C; Scagliotti GV; Dianzani C; Ferrante D; Migliore E; Magnani C; Mirabelli D; Matullo G; Dianzani I
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885614
[TBL] [Abstract][Full Text] [Related]
11. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.
Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
[TBL] [Abstract][Full Text] [Related]
14. BRCA1-associated protein 1: Tumor predisposition syndrome and Kury-Isidor syndrome, from genotype-phenotype correlation to clinical management.
West EC; Chiappetta M; Mattingly AA; Congedo MT; Evangelista J; Campanella A; Sassorossi C; Flamini S; Rossi T; Pistoni M; Abenavoli L; Margaritora S; Lococo F; Boccuto L
Clin Genet; 2024 Jun; 105(6):589-595. PubMed ID: 38506155
[TBL] [Abstract][Full Text] [Related]
15. Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome.
Abbassi YA; Le Guin C; Bornfeld N; Bechrakis NE; Zeschnigk M; Lohmann DR
Fam Cancer; 2023 Apr; 22(2):193-202. PubMed ID: 35920959
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluating the pathogenicity of the c.783+2T>C BAP1 germline variant.
Goldberg Y; Laitman Y; Ben David M; Bazak L; Lidzbarsky G; Salmon LB; Shkedi-Rafid S; Barshack I; Avivi C; Darawshe M; Shomron N; Bruchim R; Vinkler C; Yannoukakos D; Fostira F; Bernstein-Molho R; Friedman E
Hum Mutat; 2021 May; 42(5):592-599. PubMed ID: 33600035
[TBL] [Abstract][Full Text] [Related]
17. Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome.
Lebensohn A; Ghafoor A; Bloomquist L; Royer MC; Castelo-Soccio L; Karacki K; Hathaway O; Maglo T; Wagner C; Agra MG; Blakely AM; Schrump DS; Hassan R; Cowen EW
JAMA Dermatol; 2024 May; ():. PubMed ID: 38759225
[TBL] [Abstract][Full Text] [Related]
18. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
[TBL] [Abstract][Full Text] [Related]
19. Microsimulation Model for Evaluating the Cost-Effectiveness of Surveillance in
Walpole S; Hayward NK; Pritchard AL; Johansson PA
JCO Clin Cancer Inform; 2021 Jan; 5():143-154. PubMed ID: 33513031
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
